Pacific Biosciences of California, Inc. (PacBio) designs, develops, and manufactures advanced genomic sequencing systems for biological research. The company's core technology focuses on single-molecule real-time (SMRT) sequencing, which provides highly accurate long-read DNA sequencing capabilities. PacBio's product portfolio includes sequencing instruments, consumable chips, and specialized reagent kits used for complex genetic analysis. The company generates revenue primarily through the sale of its sequencing systems and the recurring sales of proprietary consumables required to run the machines. Headquartered in Menlo Park, California, PacBio serves a diverse global customer base, including academic and government research institutions, clinical laboratories, and pharmaceutical and biotechnology companies. Its technologies are utilized across various applications, such as human genetics, plant and animal sciences, infectious disease research, and oncology.
